Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
Clinical trial NCT01133613 · COMPLETED
Trial details
- NCT number
- NCT01133613
- Sponsor
- Stryker Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-10-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.